These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 17044837

  • 1. Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine.
    Mercadal S, Martinez A, Nomdedeu B, Rozman M, Gaya A, Salamero O, Campo E.
    Eur J Haematol; 2006 Nov; 77(5):442-4. PubMed ID: 17044837
    [Abstract] [Full Text] [Related]

  • 2. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC, Huang Q, Sebastian S, Hutchinson CB, Burchette J, Wang E.
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [Abstract] [Full Text] [Related]

  • 3. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
    Fong D, Kaiser A, Spizzo G, Gastl G, Tzankov A.
    Br J Haematol; 2005 Apr; 129(2):199-205. PubMed ID: 15813847
    [Abstract] [Full Text] [Related]

  • 4. Herpes lymphadenitis in association with chronic lymphocytic leukemia.
    Higgins JP, Warnke RA.
    Cancer; 1999 Oct 01; 86(7):1210-5. PubMed ID: 10506706
    [Abstract] [Full Text] [Related]

  • 5. Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis.
    Thornton PD, Bellas C, Santon A, Shah G, Pocock C, Wotherspoon AC, Matutes E, Catovsky D.
    Leuk Res; 2005 Apr 01; 29(4):389-95. PubMed ID: 15725472
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease.
    Rath J, Geisler C, Christiansen CB, Hastrup N, Madsen HO, Andersen MK, Pedersen LB, Jurlander J.
    Haematologica; 2008 Sep 01; 93(9):1424-6. PubMed ID: 18641020
    [No Abstract] [Full Text] [Related]

  • 7. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H, Murase T, Ueno H, Park JW, Yano T, Ikeda Y.
    Leuk Res; 2006 Dec 01; 30(12):1589-90. PubMed ID: 16542723
    [Abstract] [Full Text] [Related]

  • 8. Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine.
    Laurenti L, Garzia M, Sabatelli M, Piccioni P, Sora' F, Leone G.
    Haematologica; 2002 Nov 01; 87(11):ECR33. PubMed ID: 12414359
    [No Abstract] [Full Text] [Related]

  • 9. Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL.
    Chaker L, Segeren CM, Bot FJ, Maartense E.
    Eur J Haematol; 2010 Jul 01; 85(1):91-2. PubMed ID: 20331737
    [No Abstract] [Full Text] [Related]

  • 10. [Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia---a report of 35 cases].
    Lu Y, Sun LR, Pang XY, Lu ZH, Sui AH.
    Ai Zheng; 2007 Jan 01; 26(1):54-7. PubMed ID: 17222368
    [Abstract] [Full Text] [Related]

  • 11. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
    Takei K, Horikoshi A, Hosokawa Y, Sawada S, Horie T.
    Rinsho Ketsueki; 2002 Nov 01; 43(11):993-7. PubMed ID: 12508485
    [Abstract] [Full Text] [Related]

  • 12. Detection of herpes simplex virus type 1 in addition to Epstein-Bar virus in tonsils using a new multiplex polymerase chain reaction assay.
    Sahin F, Gerceker D, Karasartova D, Ozsan TM.
    Diagn Microbiol Infect Dis; 2007 Jan 01; 57(1):47-51. PubMed ID: 17141448
    [Abstract] [Full Text] [Related]

  • 13. Fludarabine for chronic lymphocytic leukemia.
    Copur MS, Ledakis P, Muhvic J.
    N Engl J Med; 2001 Apr 12; 344(15):1166; author reply 1167-8. PubMed ID: 11302141
    [No Abstract] [Full Text] [Related]

  • 14. Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy.
    Orlandi EM, Baldanti F, Citro A, Pochintesta L, Gatti M, Lazzarino M.
    Haematologica; 2008 Nov 12; 93(11):1758-60. PubMed ID: 18790800
    [No Abstract] [Full Text] [Related]

  • 15. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens.
    Engelmann I, Petzold DR, Kosinska A, Hepkema BG, Schulz TF, Heim A.
    J Med Virol; 2008 Mar 12; 80(3):467-77. PubMed ID: 18205230
    [Abstract] [Full Text] [Related]

  • 16. Acute retinal necrosis features, management, and outcomes.
    Lau CH, Missotten T, Salzmann J, Lightman SL.
    Ophthalmology; 2007 Apr 12; 114(4):756-62. PubMed ID: 17184841
    [Abstract] [Full Text] [Related]

  • 17. Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
    Bacchu S, Fegan C, Neal J.
    Br J Haematol; 2007 Nov 12; 139(3):349. PubMed ID: 17784883
    [No Abstract] [Full Text] [Related]

  • 18. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
    Rioufol C, Coiffier B.
    Onkologie; 2008 Apr 12; 31(4):157-8. PubMed ID: 18418014
    [No Abstract] [Full Text] [Related]

  • 19. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC, Ma ES, Kwong YL.
    Am J Hematol; 2005 Aug 12; 79(4):288-90. PubMed ID: 16044456
    [Abstract] [Full Text] [Related]

  • 20. Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
    O'Brien S, Moore JO, Boyd TE, Larratt LM, Skotnicki A, Koziner B, Chanan-Khan AA, Seymour JF, Bociek RG, Pavletic S, Rai KR.
    J Clin Oncol; 2007 Mar 20; 25(9):1114-20. PubMed ID: 17296974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.